loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 31651 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Ajinomoto Company

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Ajinomoto Company (1)

    filter

    01 L-LYSINE MONOHYDROCHLORIDE (1)

    filter

    01 Japan (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    AJINOMOTO CO INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    L-LYSINE MONOHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    31651
    Active
    2017-04-20
    Complete
    2021-08-27
    2020-11-30
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Drug Master Files (DMF) for 31651 of Ajinomoto Co Inc

    Looking for Drug Master Files (DMF) for 31651 of Ajinomoto Co Inc 1

    20

    Ajinomoto Co Inc, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is L-LYSINE MONOHYDROCHLORIDE, with a corresponding US DMF Number 31651.

    Remarkably, this DMF maintains an Active status since its submission on April 20, 2017, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2021, and payment made on November 30, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY